INTRODUCTION
The statistics on mortality from diabetes in most countries have been profoundly affected by the new procedure of death certification inaugurated in connection with the Sixth Revision of the International Lists of Diseases and Causes of Death. 1 This procedure came into use in 1949 in some areas and in 1950 in others. In contrast, previous revisions of the International List, which were made at approximately 10-year intervals since 1900, had little effect on the comparability of the statistics of diabetes mortality. While deaths since 1949 or 1950 have been classified for certain series by both the new and the previous procedures, the resulting figures by the latter are only approximate, primarily because the change in certification itself affects the frequency with which diabetes is mentioned. Moreover, physicians and vital statistics offices have not had sufficient experience with the new certificate and procedure to permit accurate evaluation of the effects of the change. This will take a number of years yet and until then, the recent trends in mortality from the disease will remain obscure. For all these reasons, it is necessary to divide the record of diabetes mortality into two parts, with 1949* as the dividing line or, in certain cases, 1950. The major part of this paper will deal with the record for 1948 and prior years.
TREND OF THE DEATH RATE IN THE UNITED STATES

Experience of The Metropolitan Life
Insurance Company, 1911 Company, -1948 Figure 1 shows the long-term trend in the death rate from diabetes among Industrial policyholders of the Metropolitan Life Insurance Company since 1911, on the basis of the Fifth and earlier revisions of the Inter-national List. Both crude rates and age-adjusted rates are charted. This series is brought up to 1950 but the rates for 1949 and 1950 are subject to the considerations cited in the Introduction. From 1940 to 1948, the crude death rate from the disease tended to fall but it will be noted that 1940 marked the culmination of a long upsweep in the rate, which brought it to a level about double that prevailing in most years prior to 1922. The trend of the age-adjusted or standardized rates makes clear that the shift in age distribution, primarily the steady increase in the proportion of older persons, accounts for most of this long-term rise. In 1940 to 1948 the trend of the age-adjusted rate was markedly downward, and by 1948 the rate had fallen until it was close to the early years of this experience. It is interesting to note, furthermore, that the age-adjusted rates were fairly stable for more than a decade-from 1930 to 1942.
Sex and Color
The trends of diabetes mortality have varied greatly by sex and color. This is summarized in Table 1 , which gives both crude and age-adjusted rates in calendar periods from 1920 to 1948. In all groups the long-term trend of the crude rates was upward. The rise was especially great among females, both white and colored. At the peak, the rates for females were about double those in the early years of the experience. Subsequently, the rates fell, but remained well above the initial levels, particularly in females. Changes in the age distribution of the policyholders account for a great part of the rise. Among white males, the age-adjusted rate in this insurance experience fluctuated in a fairly narrow range during the two decades, 1920 to 1944. Among white females, on the other hand, the age-adjusted rate rose with little interruption until 1940. It was then nearly 50 per cent higher than that for the years immediately preceding the inauguration of insulin treatment of diabetes, and for the period 1935-1944, the rate was more than one fourth higher than in 1920-1924. Between 1940 and 1948 the rates adjusted for age fell quite rapidly for each sex. As a result, the death rate for white males in 1945-1948 was about one fifth less than in 1920-1924, and for white females showed a rise of less than 2 per cent.
Among colored males the age-adjusted rate has fallen back in recent years to the level that prevailed 20 years earlier, but among colored females, even with the decline in the rates since 1940, the recent level of the ageadjusted rate is still about 40 per cent above that of the pre-insulin period. This radical change for colored women probably reflects the poor reporting of the disease a generation ago. It is apparent also from Table 1 that at all ages combined the mortality of colored persons in this insurance experience in recent years has not differed materially from that of white persons when allowance is made for differences in age composition of the populations. This represents the situation for the urban wage-earning population. 
General Population Experience, 1920 to 1948
In most respects, the trends in the general population between 1920 and 1948 are similar to that in the insurance experience. This is brought out in Table 2 . The general population data, however, are distorted somewhat in the war years because persons serving in the armed forces overseas, who were well screened for diabetes, are excluded from the population base used in the computations. Consequently the rates are a little higher for the total population and for males than they would be if corrections were made for this factor.* It may be rioted that in recent years the age-adjusted mortality rates for nonwhite males are substantially less than for white males. Among females, however, the rate for nonwhites has come to exceed that among whites.
Trends by Age and Sex
The trends of the death rates from diabetes by age show marked variation both over the short term and the long term. This is brought out in Figure 2 , based upon the experience of the Metropolitan Life Insurance Company among white policyholders since 1920. Again limiting the comparison to the period up through 1948, the last decade showed a substantial fall in the rates in virtually all age groups in both sexes. Among males the long-term trend also had been downward at all ages up to 55 and among females at all ages up to 45. At ages beyond these, the trend prior to the last 10 years was upward, particularly among older women. The subsequent shift in the trend at these middle and older ages has been suf- ficient to wipe out a good deal of the increase during the previous years. Consequently the death rates at the end of the period were below those of the pre-insulin •Adjusted on the basis of the age distribution of the 1940 United States population, f Estimated mid-year population, excluding armed forces overseas.
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years at every age group except after 65 among men and after 55 among women. Notable also is the remarkably low level of recent rates at the younger ages -1 or less per 100,000 at ages 1 to 24 in several years among the males and in one year among the females. The relative changes in the mortality picture by sex and age are further brought out in Table 3 , which gives the rates for the three-year period, 1946-1948, for a decade earlier, 1936-1938, and for the pre-insulin period, 1920-1922, together with the percentage changes between each of the earlier periods and the last period. The magnitude of the changes in this insurance experience is remarkable, with long-term reductions ranging from 40 per cent to 82 per cent in the age groups under 45 and with short-term reductions of 20 per cent or more in several age groups. The larger rate of decline in recent years among females as compared with males in some age groups should be considered in the light of the adverse trend for females in the earlier years.
A notable exception to the general decline in diabetes rates in recent years occurs at ages 25 to 34, where the rates in 1946-1948 were identical with those of a decade earlier. The significance of this is not clear. It may reflect merely the low level of the rates in this age group in recent years. On the other hand, diabetics in this age group have come to include an increased proportion of juvenile cases with long duration of the disease, among whom serious degenerative complications are found with great frequency. Fatalities due to these causes in this group may have been sufficient to counteract the more favorable experience among diabetics of the same ages with recent onset. The fact that the trend described is alike for both men and women gives some weight to this interpretation. Table 3 serves also to show the characteristics of the age curve for diabetics in each sex as well as the relative mortality of males and females. In both sexes there is a steady rise with advancing age to a peak in later life. Among females this rise is greater than in males after age 45. Consequently there is increasing disparity between the two sexes with regard to the level of the rates after that age. The ratio of the female to the male rate in 1946-1948 rises from nearly 150 per cent at ages 45 to 54, to more than 230 per cent at ages 55 to 64 and also at 65 to 74.
Regional Trends
Recent regional changes in diabetes mortality are presented in Table 4 , on the basis of the crude death rates by state for 1939-1941 and 1946-1948 . Whereas for the country as a whole the rates in these triennia are virtually identical, those for individual states show changes in varying degree, some of them marked. At the extremes, Montana showed a rise of nearly one third and Oregon a reduction of about one fourth. Of the 48 states and the District of Columbia, 27 showed increases, 21 decreases and 1 no change. In 4 states the decreases exceeded 10, per cent, and in 2 of them 20 per cent. Increases of 10 per cent or more occurred in 7 states, in 2 of them exceeding 20 per cent. The only resemblance to any regional pattern in these changes is a general rise in most of the South and Southwest and a drastic reduction on the Pacific Coast. There are many causes underlying these variations in rate of change of death rates by regions and states. The sharp decline on the Pacific Coast and in some other areas partly reflects the rapid growth of the population of these areas during and after the war, primarily due to migration of young people from other areas. The resulting lower average age of the population would bring down the diabetes rate. An opposite population trend occurred in the South and in certain states in the midwestern farm belt. In turn this would tend to raise the diabetes rates in those areas. These statistics by states show that uniformly the Northeastern states have the highest rates and those in the South and Southwest the lowest rates. In part these variations reflect differences in the age and sex distribution of the population, but social and economic factors as well as the availability of medical facilities are also important influences on the level of the rates.
Death Rates in Large Cities
For this purpose the cities with 500,000 population or more in 1940 have been selected, and trend comparisons have been made on the basis of the changes from 1920 and 1939-1940 to 1948 (see Table 5 ). It should be noted that the statistics for 1920 relate to deaths occurring in these cities, whereas the statistics for the other years cover all residents of these cities dying within the continental United States. It will be seen that the shortterm trend is rather mixed: 6 of these 14 large cities showed gains between 1939-1940 and 1948 ranging from 4 per cent to more than 20 per cent; 5 showed virtually no change and 3 showed declines ranging from 7 to 15 per cent. The long-term trend however, in these cities has been uniformly upward. In fact, in all but 3 cities the 1948 rates are about double those for 1920. A much smaller increase was recorded for San Francisco. Space does not permit full discussion of the reasons for the differences in the relative rate of change in the diabetes death rates in these cities, particularly over the short term where the variation is considerable, even if the authors could identify them all. Over the long range the increasingly efficient discovery of the disease and the aging of the population are prime factors in most of these cities. The increase in the proportion of older persons has generally been more pronounced in the large cities than elsewhere because most of these cities have grown comparatively little, largely as the result of the migration of young couples with growing families to the suburbs. This trend has favored an increase in the diabetes rate in the cities themselves.
It is interesting to note the relatively wide range of rates in this group of large cities-from 26.5 in San Francisco to 48.2 in New York in 1948-and also that these rates are in general well above the national figure of 26.4. Among other things, this reflects the superior facilities available in urban areas for the detection and treatment of diabetes.
COMPARISON OF DIABETES DEATH RATES FOR VARIOUS COUNTRIES
The recorded mortality from diabetes in different parts of the world shows an extremely wide range. 3 ' 4 For many countries no data at all are available. This applies primarily to the undeveloped countries, and for many years also to the areas in Eastern Europe under Soviet domination. Table 6 gives the death rates in a large number of countries for 1948, with comparisons for 1938 and 1928. Caution must be exercised in interpreting international variations in the diabetes death rates because the level of mortality from the disease is influenced by a number of factors, such as the age and sex distribution of the population, its occupational composition, the national income, the degree of urbanization, and the quality and amount of medical care available. Morever, there are differences from country to country in practices of reporting causes of death by physicians and in methods of classification of the primary cause by the offices of vital statistics, where more than one condition is stated. 5 ' 6 The United States has the highest recorded rate of all countries in the world. Canada's death rate in 1948 was second highest, about one fourth less than that in this country, whereas prior to World War I it had been little more than half the rate in this country. The 1948 There can be no doubt that genuine differences exist in the level of diabetes mortality and diabetes incidence even after correction for such factors as the differential age and sex composition of populations. Certainly, insofar as diabetes is associated with abundant nutrition, one would expect real and marked differences between the well-nourished-one might say over-nourished-peoples of this and some other western nations, and the peoples of countries where the masses do not get enough to eat. But it is hard to explain the rather substantial differences between many of the European countries which are fairly alike in important respects-their population structure, standards of living, and medical and public health organization. Consequently it would be desirable to have expert investigation of the causes of the reported differences.
Comparison of the death rates in 1948 with those of 10 and 20 years previous shows a variety of trends. Oddly enough, the increases have been usually greatest for countries with the highest rates, as for example the United States, Canada, Australia and New Zealand. For example, in the United States the 1948 rate was 11 per cent higher than a decade earlier and 12 per cent higher than 20 years earlier. For Canada these increases were 47 per cent and 83 per cent respectively. For Denmark, the rate in 1948 was 24 per cent higher than in 1928, although 19 per cent less than in 1938. In part, the upward trend in these countries reflects the increased average age of the populations, the maintenance of high standards of living, and improvement in medical care as well as intensive efforts to detect the disease.
In contrast, large decreases in the death rate from diabetes, which in part at least may be ascribed to deterioration in standards of living and medical care, are found in such countries as Austria, Spain and Japan. In Europe generally however, the limitations on food supplies in the war and postwar periods could be expected to bring down the incidence and mortality from diabetes. In England, The Netherlands and Sweden, the decline in the recorded rates is believed also to reflect changes in certification and classification of causes of death, because these countries had early put into effect the practices that were later adopted for international use in connection with the Sixth Revision of the International List.
Sex-Age Levels
Publication by the World Health Organization of detailed figures on the deaths from diabetes by sex and age for many countries for one or more recent years 3 ' 7> 8 has made possible the computation and comparison of rates from the disease in this detail (see Table 7 ). These comparisons are subject to some of the limitations already described, but at least they eliminate the factors of sex and age distribution. Unfortunately, the age groupings are not identical throughout. Space does not permit an exhaustive analysis of the data and only the major features are discussed. The analysis brings out the universality of certain characteristics by sex and age. With few exceptions the death rates from diabetes among females are higher than those for males. In several countries the margin is quite wide, the rate in females being twice as high as in males. Japan is the only major country in which a lower rate is recorded in women than in men. The death rates in the childhood and early adult ages are quite low everywhere. In few countries are death rates of more than 2 per 1,000 recorded at ages under 25. The rates increase gradually between ages 25 and 45, but after 45 mount rapidly, particularly in women. The death rates are at the maximum in old age. At the younger ages, rates show only minor differences according to sex, but past 55 there is a marked excess in the death rates of women virtually everywhere. In several countries they are double the rates for men.
When comparisons are made of the mortality rates specific for age and sex in the various countries, great differences are noted between them. For example at ages 65 and over, when the rates are at their maximum, we find these extremes even in countries that are in fairly close proximity: among men, the rate in Denmark in 1949 was 130.9 as compared with 37.8 in France and 19.6 in Finland; among women, the rate in Denmark was 184.8 as compared with 54.8 in France and 40.9 in Finland. The levels for England and Wales, Sweden and The Netherlands are not comparable with the others for reasons already pointed out, but are useful in showing the age characteristics of mortality from the disease there, as well as the comparative levels according to sex in the successive age groups.
In view of the numerous reports on the high frequency of diabetes among Jews, the statistics for the Jewish population of Israel are of especial interest because for the first time they are based on a Jewish population, the age and sex composition of which is known accurately. The data, therefore, are in certain respects more reliable than any heretofore published. However, the population covered is relatively small. It is quite mixed in origin, representing as it does persons from widely scattered countries. In addition, it must be remembered that the country has been a haven even for those with chronic disease because of the immigration policy adopted by the Israeli government. The number of deaths under age 45 is too small to be of much significance. At ages 55 to 64, the rates for both men and women are about of the same order as the higher rates observed elsewhere in the world, as in this country and in western Europe. This holds likewise for males over 65, but the rate for Israeli females in this age group is exceeded in but few countries.
RECENT STATISTICS FOR THE 'UNITED STATES BASED UPON THE SIXTH REVISION OF THE INTERNATIONAL LIST
During the three years 1949 to 1951,* the recorded death rates from diabetes in the United States, classified according to the new procedure, have been fairly stable. In 1949, the latest year for which final figures are available for the country and the only full year for which the data are classified by the Sixth Revision, the number of deaths ascribed to diabetes was 25,089, corresponding to a rate of 16.9 per ioo,ooo.
9 For 1948 the number of deaths by the Fifth Revision was 38,638, or 26.4 per 100,000.
In 1949, the figures by color and sex were: Several vital statistics offices have classified deaths for 1949 and later years according to both the Fifth and Sixth Revisions. These studies are subject to the limitations already described but it will be interesting to review some of the results.
For the country as a whole the first year's experience (1949) with the Sixth Revision, based upon a 10 per cent sample of the death certificates, showed that deaths from diabetes classified by its procedure were only 58 per cent of the total by the Fifth Revision. In other words, the total by the Sixth Revision was 42 per cent less than by the Fifth. For 1950 the deaths from diabetes by the Sixth Revision were 56 per cent of the total by the Fifth Revision or 44 per cent less.
Further analysis along these lines by age, sex, and color 10>11 is shown in Table 9 and by states in Table  10 . The latter is based upon a 10 per cent sample of death certificates for the years 1949 and 1950.
It-is clear from Table 9 that the effect of the change in procedure is least at ages under 25, somewhat less at ages 25 to 44 and most marked at ages after 45. Beyond age 45, where the bulk of the deaths from diabetes is concentrated, the effect is fairly uniform. It is about the same in males as in females, regardless of age, but there are substantial differences according to color between the white and nonwhite populations, the ratios of the numbers of deaths by the Sixth Revision to those by the Fifth being significantly lower in white than in nonwhite persons.
The degree of variation by states is very great. Even if one limits the comparison to those states in which the number of deaths in the two-year sample is fairly large, One finds, for example, a ratio as high as 79 per cent for Texas and as low as 39 per cent for California. In general, as Table 10 shows, the ratios are highest for the Southern states and lowest for the populous states in the Northeast.
It will be apparent that the effect of the change in classification will be least in those types of patients in which the direct complications of the disease, such as coma, gangrene and renal disease are most frequent. These are chiefly young diabetics or patients who for various reasons do not obtain the best modern treatment of diabetes, or fail to cooperate in treatment. Apart from this, local differences in certification practice as well as in points of view regarding the relationship of degenerative changes to diabetes are reflected in the death rates from diabetes in each area. Unfortunately, it is impossible to measure these factors. As it is, the designation of these degenerative conditions of the cardiovascular-renal system as the primary cause of death of diabetics accounts for the major part of the difference in the numbers classified by the Sixth as compared with the Fifth Revision. This has been brought out in a number of recent publications. 12 In our judgment, the application to earlier years of the results of comparability studies based upon 1949 and 1950 death certificates is inaccurate and leads to erroneous conclusions. It is best to recognize frankly that the statistics prior to 1949 are not comparable with those for subsequent years. The mortality statistics for diabetes should in the future be studied separately for the periods before and since the adoption of the Sixth Revision of the International List, with its new certification method.
DISCUSSION
The recent statistics on mortality from diabetes show a high degree of uniformity with respect to only two major characteristics. First, the disease causes more deaths in females than in males, even with allowance for the differences in the age distribution of the two sexes. The cumulative experience on diabetes mortality points to the conclusion that this difference in the frequency of the disease according to sex is real. It is noteworthy also that it is fairly well limited to ages after 40. The persistence with which mortality from diabetes in females is found to exceed that of males would indicate the influence of endocrine factors outside the pancreas. The sex differential has persisted even in those countries which deeply felt the impact of World War II. The excess mortality of females from diabetes is greatest in countries which are most favorably situated economically, in fact it has tended to grow rather than diminish in them. The United States is the prime example of this.
The second consistent characteristic of diabetes mortality is the rise with advancing age, although at no age does diabetes cause more than a small fraction of all deaths. It is significant, moreover, that among diabetics dying in middle and later life the causes of death are predominantly arteriosclerotic lesions of the vascular system. This has become increasingly true as modern therapy of the disease has drastically reduced mortality among diabetics from coma and from infections. The death rate from arteriosclerotic conditions is higher, the onset apparently earlier and the course more rapid among diabetics than nondiabetics.
Trends in diabetes mortality in the decade between 1938 and 1948 show a marked divergence between most of the countries of Europe on the one hand and the United States and the countries of the British Commonwealth on the other. The European rates of recent years are uniformly lower than before, in some countries radically so. This may to a real degree represent an actual reduction in frequency of the disease there because the people of these countries have had to tighten their belts. This would affect not only the incidence of new cases but the longevity of previously known diabetics who have been virtually forced to adhere more closely to a good diabetic regimen. However, this cannot entirely explain the trend. It is certain that the change in pattern of medical certification of causes of death has played a role in the decline in diabetes mortality in some areas at least. The procedure which the English adopted and which subsequently was embodied in the Sixth Revision of the International List had some influence on those of other European countries, and brought a drop in the recorded death rates. In some European countries, moreover, the reduction may to a degree reflect the impairment of their medical resources, both in personnel and facilities.
Unfortunately, the facts on which one can judge the significance of these sharp declines in diabetes death rates in Europe are not available. Nevertheless, there is ground for the belief that the trend of diabetes mortality there affords a practical demonstration of diabetes control on a large scale by enforced dietary restriction.
In contrast, countries which have experienced an increase or little change in diabetes mortality, such as the United States, Canada, Australia and New Zealand, have enjoyed an abundance of food, so that in part at least their death rates reflect high living standards and high food intake. At the same time, the search for diabetes has probably been most intensive in these countries, partly because of their abundant medical resources and the increased use of laboratory tests in clinical and hospital practice. In addition, the discovery of undiagnosed cases in this country has been stimulated in recent years by the Diabetes Detection Drive of the American Diabetes Association.
To a high degree, the varying levels of diabetes mortality from country to country likewise represent the influence of the factors described. Real differences in incidence and prevalence of diabetes exist, because of genetic and environmental differences between the populations of countries, but in part these differences merely represent the varying adequacy of detection and treatment of the disease.
The achievements of modern treatment of diabetes is clearly reflected in mortality statistics by the long-term decline in the death rate at the childhood and young adult ages. The drastic reduction in diabetes mortality in this period of life and the very low level of these rates today show effectively the boon which insulin brought to the young diabetic.
The recorded increase in diabetes mortality in this country at the older ages, particularly in women, which culminated about 1940, is believed to reflect an actual increase in the prevalence of the disease, but perhaps even more the discovery of increasingly large numbers of mild cases, hitherto overlooked. The reversal of this mortality trend after 1940 is to some extent at least the result of improved treatment of diabetic patients and consequent better control of their disease.
The adoption of a new form of medical certification in connection with the Sixth Revision of the International List aims to increase the uniformity of practices in this regard throughout the world. However, this is an ideal which is not likely to be realized for a long time. The detail in which morbid conditions are reported on the death certificate and the way in which this detail is evaluated in the minds of physicians will continue to vary. Beyond that, the quantity and quality of medical care will remain as factors in the accurate diagnosis of disease. This is of particular importance for a condition like diabetes. Furthermore, even when diabetes is known to exist the certification of it as a primary or a secondary cause represents not merely an opinion but often a point of view, and different physicians frequently will not agree on this matter in individual cases. Actually, the great majority of deaths of diabetics, whether ascribed to the disease or not, are due to or associated with degenerative complications. Consequently, while it has been stated that the death rates from diabetes on the new basis afford an estimate of the risk of dying from the disease rather than with it, this statement is seriously open to question. One thing is certain. The statistics from diabetes mortality no longer provide a good index to the known or the estimated prevalence of the disease. For that reason, dependable new data of this kind can only be provided by health surveys or other sources of morbidity statistics. 2. The long-term trend, of diabetes mortality in the United States has been upward, but a major part of this rise has been due to the aging of the population. The ageadjusted death rate actually declined from 1940 to 1948.
3. At the childhood and early adult ages death rates from diabetes have steadily fallen in the United States since insulin came into use. The rates at older ages showed a marked rise, particularly among females, until about 1940 but have declined considerably since then.
4. Death rates from the disease by states are generally lowest in the South and Southwest and highest in the North. 5 . Trends of the rates by states and in the large cities of the country between 1938 and 1948 show marked variation.
6. The death rates from diabetes in the various countries of the world have a relatively wide range. The rate is highest of all in the United States and next highest in some other English-speaking countries. The rates are much lower in eastern and southern Europe, in Central and South America and in Asia, and lowest of all in the undeveloped countries. The variation in rates is due in part to differing practices in medical certification of causes of death and in the evaluation of the facts reported. The true situation is not known.
7. Postwar rates in Europe are generally much lower than prewar rates.
8. The statistics by sex and age, presented for a number of countries, show almost uniformly a higher mortality in females than in males, and without exception a rise in mortality with age.
9. The death rates during 1949-1951 in the United States, based upon the Sixth Revision, have been fairly stable for the country as a whole.
10. The effect of the revised procedure varies by age, race and region, but is greatest at the middle and later ages when diabetes is most prevalent.
